Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial - Concepedia

Concepedia

Publication | Closed Access

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

31

Citations

16

References

2023

Year

Göran Dellgren, Thomas Kromann Lund, Peter Raivio, Inga Leuckfeld, J. Svahn, Erik Holmberg, Peter Skov Olsen, Maija Halme, Arnt E. Fiane, Sandra Lindstedt,

The Lancet Respiratory Medicine

3-Year IncidenceTransplantationMedicineGraft SurvivalLung Transplantation

References

	Year	Citations

Page 1